histone deacetylase inhibitors (Syrrx)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namehistone deacetylase inhibitors (Syrrx)
Drug Alias NameHDAC inhibitors (Syrrx)TWZ-112TWZ-113
ClassificationSmall molecules
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTakeda San Diego Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTakeda San Diego Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A